Pharmos Corp. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2012. For the quarter, the company reported a net loss of $0.4 million, or $0.01 per basic and diluted share compared to $0.5 million, or $0.01 per basic and diluted share, in the second quarter 2011. Loss from operations was $353,223 compared to $474,556 for the same period a year ago. Interest income was $20 compared to $60 a year ago. For the six months, the company reported a net loss of $1.0 million, or $0.02 per basic and diluted share compared to $1.1 million, or $0.02 per basic and diluted share for the six months ended June 30, 2011. Loss from operations was $904,560 compared to $1,051,311 for the same period a year ago. Interest income was $52 compared to $156 a year ago.